chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine given after 12 hours of being in the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given after 12 hours of being in the refrigerator) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given after 12 hours of being in the refrigerator). On 29-May-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given after 12 hours of being in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow up received on 01-JUN-2021 and it contains No New Information
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: missed to receive the 2nd dose on 1May2021 and received that on 21May2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed to receive the 2nd dose on 1May2021 and received that on 21May2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed to receive the 2nd dose on 1May2021 and received that on 21May2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed to receive the 2nd dose on 1May2021 and received that on 21May2021) had resolved.            No concomitant medications were provided No treatment medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Have not gotten my second vaccine yet; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Have not gotten my second vaccine yet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Have not gotten my second vaccine yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Have not gotten my second vaccine yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Decreased appetite
Clinical narrative: Taking the first dosage of the Moderno vaccine do you lose your appetite; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Taking the first dosage of the Moderno vaccine do you lose your appetite) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Taking the first dosage of the Moderno vaccine do you lose your appetite). At the time of the report, DECREASED APPETITE (Taking the first dosage of the Moderno vaccine do you lose your appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were provided
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster, Hypoaesthesia, Peripheral swelling
Clinical narrative: Shingles; Leg swelling, foot swelling; Numbness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PERIPHERAL SWELLING (Leg swelling, foot swelling) and HYPOAESTHESIA (Numbness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles), PERIPHERAL SWELLING (Leg swelling, foot swelling) and HYPOAESTHESIA (Numbness). At the time of the report, HERPES ZOSTER (Shingles), PERIPHERAL SWELLING (Leg swelling, foot swelling) and HYPOAESTHESIA (Numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue, Palpitations
Clinical narrative: palpitations after the vaccine; did not get the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations after the vaccine) and INTENTIONAL PRODUCT USE ISSUE (did not get the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (palpitations after the vaccine) and INTENTIONAL PRODUCT USE ISSUE (did not get the second dose). At the time of the report, PALPITATIONS (palpitations after the vaccine) and INTENTIONAL PRODUCT USE ISSUE (did not get the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment medication was not provided by the reporter.  Very limited information has been provided at this time. Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Very limited information has been provided at this time. Further information has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: dry cough for 2 weeks; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough for 2 weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (dry cough for 2 weeks). At the time of the report, COUGH (dry cough for 2 weeks) outcome was unknown.            No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Asthenia, Body temperature increased, Headache, Inappropriate schedule of product administration
Clinical narrative: Forget many things; Feels very sick; Memory loss; No energy; Fever 102 Fahrenheit; Headache on both sides; Received 2nd dose after recommended interval, more than 35 Days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose after recommended interval, more than 35 Days), MEMORY IMPAIRMENT (Forget many things), MALAISE (Feels very sick), AMNESIA (Memory loss) and ASTHENIA (No energy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia and Bronchitis NOS. Concurrent medical conditions included Allergy NOS (She has allergy to many things.).   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose after recommended interval, more than 35 Days). On 16-Apr-2021, the patient experienced MEMORY IMPAIRMENT (Forget many things), MALAISE (Feels very sick), AMNESIA (Memory loss), ASTHENIA (No energy), PYREXIA (Fever 102 Fahrenheit) and HEADACHE (Headache on both sides). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose after recommended interval, more than 35 Days), MEMORY IMPAIRMENT (Forget many things), MALAISE (Feels very sick), AMNESIA (Memory loss), ASTHENIA (No energy), PYREXIA (Fever 102 Fahrenheit) and HEADACHE (Headache on both sides) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature increased: 102 she had fever 102 Fahrenheit and last for 3 days.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included five different types of Inhalers. Concomitant medications were not provided.   This case was linked to MOD-2021-194101 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Memory impairment, Pyrexia
Clinical narrative: Forget many things; Feels very sick; Memory loss; No energy; Fever 102 Fahrenheit; Headache on both sides; Received 2nd dose after recommended interval, more than 35 Days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose after recommended interval, more than 35 Days), MEMORY IMPAIRMENT (Forget many things), MALAISE (Feels very sick), AMNESIA (Memory loss) and ASTHENIA (No energy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia and Bronchitis NOS. Concurrent medical conditions included Allergy NOS (She has allergy to many things.).   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose after recommended interval, more than 35 Days). On 16-Apr-2021, the patient experienced MEMORY IMPAIRMENT (Forget many things), MALAISE (Feels very sick), AMNESIA (Memory loss), ASTHENIA (No energy), PYREXIA (Fever 102 Fahrenheit) and HEADACHE (Headache on both sides). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose after recommended interval, more than 35 Days), MEMORY IMPAIRMENT (Forget many things), MALAISE (Feels very sick), AMNESIA (Memory loss), ASTHENIA (No energy), PYREXIA (Fever 102 Fahrenheit) and HEADACHE (Headache on both sides) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature increased: 102 she had fever 102 Fahrenheit and last for 3 days.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included five different types of Inhalers. Concomitant medications were not provided.   This case was linked to MOD-2021-194101 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Menometrorrhagia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MENOMETRORRHAGIA (I started menstrual bleeding even though I was post menopausal for 2 years.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENOMETRORRHAGIA (I started menstrual bleeding even though I was post menopausal for 2 years.). At the time of the report, MENOMETRORRHAGIA (I started menstrual bleeding even though I was post menopausal for 2 years.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications reported. No treatment information was provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Both doses are 48 days apart; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Both doses are 48 days apart) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Both doses are 48 days apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Both doses are 48 days apart) outcome was unknown.            Treatment information was not reported. Concomitant information was not reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Pain
Clinical narrative: Body discomfort; Pain; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Body discomfort), PAIN (Pain) and FATIGUE (Tiredness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Body discomfort), PAIN (Pain) and FATIGUE (Tiredness). At the time of the report, DISCOMFORT (Body discomfort), PAIN (Pain) and FATIGUE (Tiredness) outcome was unknown.            No relevant concomitant medications were reported.  The patient did not receive any treatment.    Most recent FOLLOW-UP information incorporated above includes: On 27-Jun-2021: no significant information.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Tendonitis
Clinical narrative: Tendonitis; Joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TENDONITIS (Tendonitis) and ARTHRALGIA (Joint pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDONITIS (Tendonitis) and ARTHRALGIA (Joint pain). At the time of the report, TENDONITIS (Tendonitis) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was reported.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received a Pfizer COVID-19 vaccine after getting Moderna as a first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received a Pfizer COVID-19 vaccine after getting Moderna as a first dose) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received a Pfizer COVID-19 vaccine after getting Moderna as a first dose). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Patient received a Pfizer COVID-19 vaccine after getting Moderna as a first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that patient erroneously received a Pfizer COVID-19 vaccine as a second dose on 28May 2021 Lot #EW0187,expiration date 20Aug2021 on left arm intramuscularly. No Concomitant medications was reported. No Treatment medication was reported
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: bad rash all over my body; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (bad rash all over my body) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (bad rash all over my body). At the time of the report, RASH (bad rash all over my body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (syringe issue and liquid leaked from the barrel down her arm/ did not get the full dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 017C21A) for COVID-19 vaccination.  No Medical History information was reported. On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (syringe issue and liquid leaked from the barrel down her arm/ did not get the full dose). At the time of the report, UNDERDOSE (syringe issue and liquid leaked from the barrel down her arm/ did not get the full dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported that patient had concern that did not get full dose due to syringe liquid leakage issue from barrel down to arm. Pharmacist stated that product was supplied from state which is Easy Touch Fluringe FlipLock Safety Syringe of 25 gauge 3 cc inch having an expiry date 11Mar2026, manufacturing date 12Mar2021, lot number 53419, Item number 825231. No Concomitant medication was reported. No Treatment medication was reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: experienced a high pitch tone in the head described as ringing but it is from the head persistent until 01Jun2021; This spontaneous case was reported by a patient and describes the occurrence of TINNITUS (experienced a high pitch tone in the head described as ringing but it is from the head persistent until 01Jun2021) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 028A21H) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (experienced a high pitch tone in the head described as ringing but it is from the head persistent until 01Jun2021). At the time of the report, TINNITUS (experienced a high pitch tone in the head described as ringing but it is from the head persistent until 01Jun2021) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: the Follow up received on 14-JUN-2021, patient details updated, event onset date updated , causality updated.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Product administered to patient of inappropriate age
Clinical narrative: Vaccine given to a 16 year old; Headache; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to a 16 year old), HEADACHE (Headache) and MYALGIA (Arm pain) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A. Expiration date unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to a 16 year old), HEADACHE (Headache) and MYALGIA (Arm pain). On 03-May-2021, HEADACHE (Headache) and MYALGIA (Arm pain) had resolved. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to a 16 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. The treatment information was unknown. Action taken with mRNA-1273 in response to the events were not applicable.  Vaccination was given to the patient whose age was below18 years old.
Sex: M
Vaccine: COVID19
Symptoms: Malaise, SARS-CoV-2 test
Clinical narrative: Was not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Was not feeling well) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Was not feeling well). At the time of the report, MALAISE (Was not feeling well) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.         Patient received his 2nd vaccine shot on 22-MAY-????. Patient had tested positive. no concomitant medications are provided. treatment to the events not reported.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: vaccine end up going down the patient arm, not sure how much dose the patient received; syringe needle was not screwed away; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (vaccine end up going down the patient arm, not sure how much dose the patient received) and DEVICE CONNECTION ISSUE (syringe needle was not screwed away) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19  Vaccination.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced UNDERDOSE (vaccine end up going down the patient arm, not sure how much dose the patient received) and DEVICE CONNECTION ISSUE (syringe needle was not screwed away). On 01-Jun-2021, UNDERDOSE (vaccine end up going down the patient arm, not sure how much dose the patient received) and DEVICE CONNECTION ISSUE (syringe needle was not screwed away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported No treatment medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up information received on 30-JUN-2021 and does not contain No New Information.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea issues since 2 weeks after my first vaccination and it is still continuing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea issues since 2 weeks after my first vaccination and it is still continuing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea issues since 2 weeks after my first vaccination and it is still continuing). At the time of the report, DIARRHOEA (diarrhea issues since 2 weeks after my first vaccination and it is still continuing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information and concomitant medications were not provided.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and MYALGIA (Muscle ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced HEADACHE (Headache) and MYALGIA (Muscle ache). At the time of the report, HEADACHE (Headache) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was reported as none. Treatment information was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching all over body; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over body) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching all over body). At the time of the report, PRURITUS (Itching all over body) outcome was unknown.            Concomitant product information was not provided.   Reporter stated they were vaccinated a couple months ago with Moderna COVID-19 Vaccine. Reporter experienced itching all over body with no rash twice.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever after vaccination). At the time of the report, PYREXIA (Fever after vaccination) outcome was unknown.            Concomitant product use was not provider by the reporter.   Treatment information were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: A rash on my back and neck; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (A rash on my back and neck) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (A rash on my back and neck). At the time of the report, RASH (A rash on my back and neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received his first dose of the Moderna vaccine Jan2021 and the second dose on 27May2021,; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received his first dose of the Moderna vaccine Jan2021 and the second dose on 27May2021,) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In January 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received his first dose of the Moderna vaccine Jan2021 and the second dose on 27May2021,). On 27-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received his first dose of the Moderna vaccine Jan2021 and the second dose on 27May2021,) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications provided  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-149035 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Limb discomfort, Neuralgia, Pain
Clinical narrative: Sore arm; Felt like I got run over by a truck; experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands; nerve pain; swelling; pain of both wrists and hands; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Felt like I got run over by a truck), LIMB DISCOMFORT (experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands), NEURALGIA (nerve pain) and SWELLING (swelling) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A2V8 and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfa Drugs), Drug allergy (Cipro), Drug allergy (Augmentin), Blood pressure increased, High cholesterol and Osteoarthritis. Concomitant products included VITAMINS NOS, LEVOTHYROXINE, LISINOPRIL, ATENOLOL, DICYCLOMINE [DICYCLOVERINE], LOVASTATIN and CENTRUM FOR WOMEN for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Felt like I got run over by a truck), LIMB DISCOMFORT (experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands), NEURALGIA (nerve pain), SWELLING (swelling), PAIN (pain of both wrists and hands) and CHILLS (Chills). The patient was treated with GABAPENTIN for Nerve pain, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Felt like I got run over by a truck), NEURALGIA (nerve pain), SWELLING (swelling) and CHILLS (Chills) outcome was unknown and LIMB DISCOMFORT (experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands) and PAIN (pain of both wrists and hands) had not resolved.            Patient was taking medication for pain and for swelling.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Updated email of the patient, added reporter, medical history. Added new events of pain and swelling. Updated the outcome of the event of arm discomfort.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Swelling
Clinical narrative: Sore arm; Felt like I got run over by a truck; experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands; nerve pain; swelling; pain of both wrists and hands; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Felt like I got run over by a truck), LIMB DISCOMFORT (experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands), NEURALGIA (nerve pain) and SWELLING (swelling) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A2V8 and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfa Drugs), Drug allergy (Cipro), Drug allergy (Augmentin), Blood pressure increased, High cholesterol and Osteoarthritis. Concomitant products included VITAMINS NOS, LEVOTHYROXINE, LISINOPRIL, ATENOLOL, DICYCLOMINE [DICYCLOVERINE], LOVASTATIN and CENTRUM FOR WOMEN for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Felt like I got run over by a truck), LIMB DISCOMFORT (experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands), NEURALGIA (nerve pain), SWELLING (swelling), PAIN (pain of both wrists and hands) and CHILLS (Chills). The patient was treated with GABAPENTIN for Nerve pain, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Felt like I got run over by a truck), NEURALGIA (nerve pain), SWELLING (swelling) and CHILLS (Chills) outcome was unknown and LIMB DISCOMFORT (experienced difficult using their hands from the elbows down to the fingers in both arms/loss of function of both wrists and hands) and PAIN (pain of both wrists and hands) had not resolved.            Patient was taking medication for pain and for swelling.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Updated email of the patient, added reporter, medical history. Added new events of pain and swelling. Updated the outcome of the event of arm discomfort.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: Lump at the injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lump at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Lump at the injection site). At the time of the report, VACCINATION SITE MASS (Lump at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications information were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: After my second Moderna vaccine shot I got tennitus; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (After my second Moderna vaccine shot I got tennitus) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (After my second Moderna vaccine shot I got tennitus). At the time of the report, TINNITUS (After my second Moderna vaccine shot I got tennitus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Sticky skin, Vaccination site reaction
Clinical narrative: I am magnetic at the site of injections; Objects sticking to me like scissors, butter knife, toe nail clippers, staples, coins, keys, and anything that is mostly stainless steel.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (I am magnetic at the site of injections) and STICKY SKIN (Objects sticking to me like scissors, butter knife, toe nail clippers, staples, coins, keys, and anything that is mostly stainless steel.) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stomach ulcer.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (I am magnetic at the site of injections) and STICKY SKIN (Objects sticking to me like scissors, butter knife, toe nail clippers, staples, coins, keys, and anything that is mostly stainless steel.). At the time of the report, VACCINATION SITE REACTION (I am magnetic at the site of injections) and STICKY SKIN (Objects sticking to me like scissors, butter knife, toe nail clippers, staples, coins, keys, and anything that is mostly stainless steel.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-194156 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection area is red; Swollen; Warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection area is red), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE WARMTH (Warm to touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection area is red), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE WARMTH (Warm to touch). At the time of the report, VACCINATION SITE ERYTHEMA (Injection area is red), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE WARMTH (Warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication information were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling). At the time of the report, PARAESTHESIA (Tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Hot flush
Clinical narrative: Hot flashes throughout the day; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flashes throughout the day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (Hot flashes throughout the day). At the time of the report, HOT FLUSH (Hot flashes throughout the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided  No treatment medications was provided     Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Asthenia, Headache, Malaise, Memory impairment
Clinical narrative: Headache on both sides; Fever 102 Fahrenheit; Feels very sick; Forget many things; Memory loss; No energy; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache on both sides), PYREXIA (Fever 102 Fahrenheit), MALAISE (Feels very sick), MEMORY IMPAIRMENT (Forget many things) and AMNESIA (Memory loss) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia and Bronchitis.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced HEADACHE (Headache on both sides). an unknown date, the patient experienced PYREXIA (Fever 102 Fahrenheit), MALAISE (Feels very sick), MEMORY IMPAIRMENT (Forget many things), AMNESIA (Memory loss) and ASTHENIA (No energy). At the time of the report, HEADACHE (Headache on both sides), PYREXIA (Fever 102 Fahrenheit), MALAISE (Feels very sick), MEMORY IMPAIRMENT (Forget many things), AMNESIA (Memory loss) and ASTHENIA (No energy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Pyrexia: 102 f (High) 102 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  She had allergy to many things. She was used 5 different types of inhalers.   This case was linked to MOD-2021-193996 (Patient Link).